Background: Dronedarone is a new antiarrhythmic drug that is being developed for the treatment of patients with atrial fibrillation.Methods: We conducted a multicenter trial to evaluate the use of dronedarone in 4628 pat.....
相关链接:PDF全文 Background A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infa.....